According to a recent paper by a Swiss research institute, various processes in the body are regulated by a 24-hour circadian rhythm, and it is suggested that the “timing” is also a crucial factor in cancer treatment.
The study analyzed various published data to examine the relationship between “timing” and cancer. The researchers found that cancer cells control the development, progression, and metastasis of cancer by generating proteins at different times of the day, and the timing may also affect the accuracy of cancer diagnosis (biopsy and CTC testing) and treatment outcomes.
For example, breast cancer tends to metastasize at night, while prostate cancer tends to metastasize during the day. In terms of treatment, melanoma patients who took immunotherapy drugs before 4:30 PM had nearly double the survival rate compared to those who took it after that time.
Additionally, in therapies targeting the cancer-specific enzyme CYP1B1, it is essential to administer them during the morning to evening when CYP1B1 is activated. There are still many unknowns regarding the relationship between time and cancer, but it may become an important consideration in cancer treatments, including intravenous therapy and nutritional therapy, in the future.
Munenori Matsuzawa
References：
Diamantopoulou Z. et al. A new time dimension in the fight against metastasis. Trends in Cell Biology, 2023
プロフィール
- 青山メディカルクリニック 院長
- 近畿大学医学部卒業。慶應義塾大学病院形成外科入局し、佐野厚生総合病院形成外科へ。その後、横浜市立市民病院形成外科として務める。埼玉医科総合医療センター形成外科・美容外科を経て、銀座美容外科クリニック新宿院院長として従事する。その後、青山メディカルクリニック開設し、今に至る。
新着記事
エクソソーム2023年8月19日Changes due to aging of epidermal stem cells.
エクソソーム2023年8月18日表皮幹細胞の加齢による変化
エクソソーム2023年8月16日Main Symptoms of Photoaging in the Epidermis
コラム2023年8月15日表皮の光老化の主な症状について
